What is known about the health of the mayor of São Paulo



[ad_1]

The mayor of São Paulo, Bruno Covas (PSDB), entered the Sírio-Libanês Hospital last Wednesday night (13) after having reported discomfort in the abdomen. According to the medical report, he is “clinically very well” and under medical observation.

The first results of the tests carried out point to the possibility of inflammation of the colon. A new bulletin is expected to be published today (14).

The mayor fights cancer in the lymph nodes, discovered in November last year, and undergoes immunotherapy. The latest evidence, published in late April, indicated that the procedure “is being effective.”

Cancer was discovered in November.

Covas discovered cancer on November 23, when he was admitted to treat a skin infection, also in Sírio-Libanês. He was diagnosed with erysipelas, an inflammation caused by bacteria that infect wounds like insect bites and fungal infections.

On the 25th of that month, examinations revealed an image of venous thrombosis of the fibular veins and, two days later, a malignant tumor was found in the digestive condition, between the esophagus and the stomach, with a unique metastasis in the liver.

The mayor started chemotherapy for a total of eight sessions in late October and, according to medical reports, reacted well to the treatment. The tumor even showed signs of regression in early December, and doctors ruled out surgery.

On the night of December 11, however, he was referred to the ICU (Intensive Care Unit) of the Syrian-Lebanese with internal bleeding. They punctured a hepatic artery during a procedure to demarcate the tumor lesion, in the middle of chemotherapy treatment.

He was released a week later, with authorization to continue exercising his professional activities.

Mayor undergoes immunotherapy since February

Even after eight chemotherapy sessions, a biopsy performed in February revealed that Covas’ cancer persisted. Then the doctors decided to start immunotherapy sessions.

The treatment uses monoclonal antibodies to stimulate the immune system in sessions of approximately 30 minutes every three weeks. The remedy has an average time of approximately two years and can bring some gastrointestinal, endocrine and skin changes.

The latest routine tests, released on April 28, indicated that the procedure was “being effective” in fighting the disease. The next exams were scheduled for the end of June.

[ad_2]